Accounting for future costs in medical cost-effectiveness analysis

被引:318
作者
Meltzer, D [1 ]
机构
[1] NATL BUR ECON RES,CHICAGO,IL 60637
关键词
cost-effectiveness analysis; utility maximization; welfare economics; cost-benefit analysis; health care costs;
D O I
10.1016/S0167-6296(96)00507-3
中图分类号
F [经济];
学科分类号
02 ;
摘要
Most medical cost-effectiveness analyses include future costs only for related illnesses, but this approach is controversial. This paper demonstrates that cost-effectiveness analysis is consistent with lifetime utility maximization only if it includes all future medical and non-medical expenditures. Estimates of the magnitude of these future costs suggest that they may substantially alter both the absolute and relative cost-effectiveness of medical interventions, particularly when an intervention increases length of life more than quality of life. In older populations, current methods overstate the cast-effectiveness of interventions which extend life compared to interventions which improve the quality of life.
引用
收藏
页码:33 / 64
页数:32
相关论文
共 50 条
  • [31] Cost-effectiveness analysis of quadrivalent influenza vaccine in Spain
    Garcia, Amos
    Ortiz de Lejarazu, Raul
    Reina, Jordi
    Callejo, Daniel
    Cuervo, Jesus
    Morano Larragueta, Raul
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (09) : 2269 - 2277
  • [32] On valuing morbidity, cost-effectiveness analysis, and being rude
    Kenkel, D
    JOURNAL OF HEALTH ECONOMICS, 1997, 16 (06) : 749 - 757
  • [33] A cost-effectiveness analysis of surgical versus medical management of early pregnancy loss
    Rausch, Mary
    Lorch, Scott
    Chung, Karine
    Frederick, Margaret
    Zhang, Jun
    Barnhart, Kurt
    FERTILITY AND STERILITY, 2012, 97 (02) : 355 - U379
  • [34] Stroke Care Costs and Cost-Effectiveness to Inform Health Policy
    Bettger, Janet Prvu
    Cadilhac, Dominique A.
    STROKE, 2022, 53 (06) : 2078 - 2081
  • [35] Cost-effectiveness analysis with risk aversion
    Zivin, JG
    HEALTH ECONOMICS, 2001, 10 (06) : 499 - 508
  • [36] AN ANALYSIS OF THE COST-EFFECTIVENESS OF THE IMPLANTABLE DEFIBRILLATOR
    KUPPERMANN, M
    LUCE, BR
    MCGOVERN, B
    PODRID, PJ
    BIGGER, JT
    RUSKIN, JN
    CIRCULATION, 1990, 81 (01) : 91 - 100
  • [37] Longevity bias in cost-effectiveness analysis
    Liu, Liqun
    Rettenmaier, Andrew J.
    Saving, Thomas R.
    HEALTH ECONOMICS, 2008, 17 (04) : 523 - 534
  • [38] Ethical issues in cost-effectiveness analysis
    Pinkerton, SD
    Johnson-Masotti, AP
    Derse, A
    Layde, PM
    EVALUATION AND PROGRAM PLANNING, 2002, 25 (01) : 71 - 83
  • [39] POLSSS: overview and cost-effectiveness analysis
    Walker, WE
    SAFETY SCIENCE, 2000, 35 (1-3) : 105 - 121
  • [40] ON THE DECISION RULES OF COST-EFFECTIVENESS ANALYSIS
    JOHANNESSON, M
    WEINSTEIN, MC
    JOURNAL OF HEALTH ECONOMICS, 1993, 12 (04) : 459 - 467